Crossmark

What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks

Crossref DOI link: https://doi.org/10.1039/D0DT02478C

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

de Paiva, Raphael E. F. https://orcid.org/0000-0003-2549-0344
Marçal Neto, Antônio https://orcid.org/0000-0003-1027-6134
Santos, Igor A. https://orcid.org/0000-0001-7750-4045
Jardim, Ana C. G. https://orcid.org/0000-0002-6348-7923
Corbi, Pedro P.

Bergamini, Fernando R. G. https://orcid.org/0000-0002-8357-3044
Funding

Funding for this research was provided by:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.506794/2020-01, Finance Code 001)

Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/21537-6, 2018/12062-4)

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-00587-14, SICONV 793988/2013, APQ-03385-18)

Royal Society (NA 150195)
License Information

Accepted Manuscript valid from 2021-09-03
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Raphael E. F. de Paiva (ORCID)

: Raphael E. F. de Paiva (ResearcherID)

: Antônio Marçal Neto (ORCID)

: Igor A. Santos (ORCID)

: Ana C. G. Jardim (ORCID)

: Ana C. G. Jardim (ResearcherID)

: Pedro P. Corbi (ResearcherID)

: Fernando R. G. Bergamini (ORCID)

: Fernando R. G. Bergamini (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 14 July 2020; Accepted 31 August 2020; Accepted Manuscript published 3 September 2020; Advance Article published 8 October 2020; Version of Record published 25 November 2020

Document is current

Any future updates will be listed below